Lada Nuzhna founded General Control to develop durable, reversible multi-gene epigenetic medicines for age-related disease. Previously, she co-founded Impetus Grants, which raised and allocated more than $34 million for aging research.

Claimed by the subject

Lada Nuzhna founded General Control to develop durable, reversible multi-gene epigenetic medicines for age-related disease. Previously, she co-founded Impetus Grants, which raised and allocated more than $34 million for aging research.

Career

Lada Nuzhna studied at Northwestern University (Physics and Computer Science).

Founder and CEO at General Control until Present
Co-founder and Program Director at Impetus Grants from 2021 to 2024

Cosigns Received

These Cosigners think Lada will be a star

generalcontrol.inc

General Control’s Vision for Epigenetic Medicines

The company’s thesis for programmable therapies that coordinate gene expression across complex age-related disease networks.

Open ↗
Media appearance

A New Bid to Control the Genome

Ashlee Vance profiles Nuzhna and General Control’s approach to multiplexed epigenetic editing.

corememory.com · Open ↗

Lada's Collections

Lada's Lists

In these lists

Cosigns Given